MedTrace Logo

Treatment of Breast Fibroadenoma Targeted Tissue With HIFU

NCT03044054 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2026-05-01

No results posted yet for this study

Summary

This study evaluates the efficacy and the safety of the HIFU for the treatment of breast fibroadenoma.

Conditions

  • Breast Fibroadenoma

Interventions

DEVICE

ECHOPULSE

HIFU Under ultrasound guidance

Sponsors & Collaborators

  • Theraclion

    lead INDUSTRY

Principal Investigators

  • Michel NUTA, MD · Theraclion

Study Design

Allocation
NA
Purpose
TREATMENT
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2026-03-31
Completion
2026-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03044054 on ClinicalTrials.gov